IFNAR1 controls autocrine type I IFN regulation of PD-L1 expression in myeloid-derived suppressor cells

Wei Xiao, John D. Klement, Chunwan Lu, Mohammed L. Ibrahim, Kebin Liu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Tumor cells respond to IFN-g of activated T cells to upregulate programmed death-ligand 1 (PD-L1) in the tumor microenvironment as an adaptive immune resistance mechanism. Tumor cells also express oncogene-driven PD-L1. PD-L1 is also expressed on myeloid-derived suppressor cells (MDSCs). It is known that both type I and II IFNs upregulate PD-L1 expression in MDSCs. However, the molecular mechanism underlying PD-L1 expression in MDSCs is still largely unknown. We report in this article that MDSCs exhibit constitutive STAT1 phosphorylation in vitro without exogenous IFNs, indicating a constitutive active JAK-STAT signaling pathway in mouse MDSCs in vitro. Furthermore, IFN-a and IFN-b but not IFN-g are endogenously expressed in the MDSC cell line in vitro and in tumor-induced MDSCs in vivo. Neutralizing type I IFN or inhibiting the JAK-STAT signaling pathway significantly decreased constitutive PD-L1 expression in MDSCs in vitro. However, neither IFN-a expression level nor IFN-b expression level is correlated with PD-L1 expression level in MDSCs; instead, the level of IFN receptor type I (IFNAR1) is correlated with PD-L1 expression levels in MDSCs. Consequently, knocking out IFNAR1 in mice diminished PD-L1 expression in tumor-induced MDSCs. Therefore, we determined that 1) PD-L1 expression in MDSCs is activated by type I IFN through an autocrine manner and 2) the expression level of PD-L1 is controlled at least in part by the IFNAR1 level on MDSCs. Our data indicate that MDSCs may maintain their PD-L1 expression via autocrine type I IFN to exert their suppressive activity in the absence of IFN-g from the suppressed T cells in the tumor microenvironment.

Original languageEnglish (US)
Pages (from-to)264-277
Number of pages14
JournalJournal of Immunology
Volume201
Issue number1
DOIs
StatePublished - Jul 1 2018

Fingerprint

Ligands
Tumor Microenvironment
Myeloid-Derived Suppressor Cells
Neoplasms
Up-Regulation
T-Lymphocytes
Oncogenes
Phosphorylation
Cell Line
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

IFNAR1 controls autocrine type I IFN regulation of PD-L1 expression in myeloid-derived suppressor cells. / Xiao, Wei; Klement, John D.; Lu, Chunwan; Ibrahim, Mohammed L.; Liu, Kebin.

In: Journal of Immunology, Vol. 201, No. 1, 01.07.2018, p. 264-277.

Research output: Contribution to journalArticle

@article{59a21036f9784417961f7a60a1fb9268,
title = "IFNAR1 controls autocrine type I IFN regulation of PD-L1 expression in myeloid-derived suppressor cells",
abstract = "Tumor cells respond to IFN-g of activated T cells to upregulate programmed death-ligand 1 (PD-L1) in the tumor microenvironment as an adaptive immune resistance mechanism. Tumor cells also express oncogene-driven PD-L1. PD-L1 is also expressed on myeloid-derived suppressor cells (MDSCs). It is known that both type I and II IFNs upregulate PD-L1 expression in MDSCs. However, the molecular mechanism underlying PD-L1 expression in MDSCs is still largely unknown. We report in this article that MDSCs exhibit constitutive STAT1 phosphorylation in vitro without exogenous IFNs, indicating a constitutive active JAK-STAT signaling pathway in mouse MDSCs in vitro. Furthermore, IFN-a and IFN-b but not IFN-g are endogenously expressed in the MDSC cell line in vitro and in tumor-induced MDSCs in vivo. Neutralizing type I IFN or inhibiting the JAK-STAT signaling pathway significantly decreased constitutive PD-L1 expression in MDSCs in vitro. However, neither IFN-a expression level nor IFN-b expression level is correlated with PD-L1 expression level in MDSCs; instead, the level of IFN receptor type I (IFNAR1) is correlated with PD-L1 expression levels in MDSCs. Consequently, knocking out IFNAR1 in mice diminished PD-L1 expression in tumor-induced MDSCs. Therefore, we determined that 1) PD-L1 expression in MDSCs is activated by type I IFN through an autocrine manner and 2) the expression level of PD-L1 is controlled at least in part by the IFNAR1 level on MDSCs. Our data indicate that MDSCs may maintain their PD-L1 expression via autocrine type I IFN to exert their suppressive activity in the absence of IFN-g from the suppressed T cells in the tumor microenvironment.",
author = "Wei Xiao and Klement, {John D.} and Chunwan Lu and Ibrahim, {Mohammed L.} and Kebin Liu",
year = "2018",
month = "7",
day = "1",
doi = "10.4049/jimmunol.1800129",
language = "English (US)",
volume = "201",
pages = "264--277",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - IFNAR1 controls autocrine type I IFN regulation of PD-L1 expression in myeloid-derived suppressor cells

AU - Xiao, Wei

AU - Klement, John D.

AU - Lu, Chunwan

AU - Ibrahim, Mohammed L.

AU - Liu, Kebin

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Tumor cells respond to IFN-g of activated T cells to upregulate programmed death-ligand 1 (PD-L1) in the tumor microenvironment as an adaptive immune resistance mechanism. Tumor cells also express oncogene-driven PD-L1. PD-L1 is also expressed on myeloid-derived suppressor cells (MDSCs). It is known that both type I and II IFNs upregulate PD-L1 expression in MDSCs. However, the molecular mechanism underlying PD-L1 expression in MDSCs is still largely unknown. We report in this article that MDSCs exhibit constitutive STAT1 phosphorylation in vitro without exogenous IFNs, indicating a constitutive active JAK-STAT signaling pathway in mouse MDSCs in vitro. Furthermore, IFN-a and IFN-b but not IFN-g are endogenously expressed in the MDSC cell line in vitro and in tumor-induced MDSCs in vivo. Neutralizing type I IFN or inhibiting the JAK-STAT signaling pathway significantly decreased constitutive PD-L1 expression in MDSCs in vitro. However, neither IFN-a expression level nor IFN-b expression level is correlated with PD-L1 expression level in MDSCs; instead, the level of IFN receptor type I (IFNAR1) is correlated with PD-L1 expression levels in MDSCs. Consequently, knocking out IFNAR1 in mice diminished PD-L1 expression in tumor-induced MDSCs. Therefore, we determined that 1) PD-L1 expression in MDSCs is activated by type I IFN through an autocrine manner and 2) the expression level of PD-L1 is controlled at least in part by the IFNAR1 level on MDSCs. Our data indicate that MDSCs may maintain their PD-L1 expression via autocrine type I IFN to exert their suppressive activity in the absence of IFN-g from the suppressed T cells in the tumor microenvironment.

AB - Tumor cells respond to IFN-g of activated T cells to upregulate programmed death-ligand 1 (PD-L1) in the tumor microenvironment as an adaptive immune resistance mechanism. Tumor cells also express oncogene-driven PD-L1. PD-L1 is also expressed on myeloid-derived suppressor cells (MDSCs). It is known that both type I and II IFNs upregulate PD-L1 expression in MDSCs. However, the molecular mechanism underlying PD-L1 expression in MDSCs is still largely unknown. We report in this article that MDSCs exhibit constitutive STAT1 phosphorylation in vitro without exogenous IFNs, indicating a constitutive active JAK-STAT signaling pathway in mouse MDSCs in vitro. Furthermore, IFN-a and IFN-b but not IFN-g are endogenously expressed in the MDSC cell line in vitro and in tumor-induced MDSCs in vivo. Neutralizing type I IFN or inhibiting the JAK-STAT signaling pathway significantly decreased constitutive PD-L1 expression in MDSCs in vitro. However, neither IFN-a expression level nor IFN-b expression level is correlated with PD-L1 expression level in MDSCs; instead, the level of IFN receptor type I (IFNAR1) is correlated with PD-L1 expression levels in MDSCs. Consequently, knocking out IFNAR1 in mice diminished PD-L1 expression in tumor-induced MDSCs. Therefore, we determined that 1) PD-L1 expression in MDSCs is activated by type I IFN through an autocrine manner and 2) the expression level of PD-L1 is controlled at least in part by the IFNAR1 level on MDSCs. Our data indicate that MDSCs may maintain their PD-L1 expression via autocrine type I IFN to exert their suppressive activity in the absence of IFN-g from the suppressed T cells in the tumor microenvironment.

UR - http://www.scopus.com/inward/record.url?scp=85048993516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048993516&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1800129

DO - 10.4049/jimmunol.1800129

M3 - Article

C2 - 29752314

AN - SCOPUS:85048993516

VL - 201

SP - 264

EP - 277

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -